Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Recurrence × regorafenib × 30 days × Clear all

Sponsor

Conditions

Colorectal Neoplasms 6 Sarcoma, Ewing 2 Sarcoma 2 Esophageal Neoplasms 2 Carcinoma, Hepatocellular 2 Uterine Cervical Neoplasms 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Malignant Tumors 1 Small Cell Lung Carcinoma 1 Patient Compliance 1 Pathologic Complete Response 1 Osteosarcoma 1 Neoplasms 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Melanoma 1 Lymphoma, Non-Hodgkin 1 Liver Metastasis Colon Cancer 1 Leiomyosarcoma 1 Histiocytoma, Malignant Fibrous 1 Hemangiosarcoma 1 Glioblastoma 1 Gastrointestinal Neoplasms 1 Esophageal Squamous Cell Carcinoma 1 Chondrosarcoma 1 Central Nervous System Neoplasms 1 Carcinoma, Transitional Cell 1 Carcinoma, Squamous Cell 1 Carcinoma, Renal Cell 1

Interventions

Cyclophosphamide 10 fludarabine 8 Rituximab 8 Dexamethasone 8 pembrolizumab 7 venetoclax 6 glofitamab 5 Lenalidomide 5 obinutuzumab 4 Etoposide 4 Calcium Dobesilate 4 pomalidomide 3 Temozolomide 3 Radiotherapy 3 Doxorubicin 3 Cytarabine 3 Carboplatin 3 zanubrutinib 2 tocilizumab 2 tisagenlecleucel 2 selinexor 2 ruxolitinib 2 ibrutinib 2 enzalutamide 2 dexamethasone acetate 2 dexamethasone 21-phosphate 2 carfilzomib 2 blinatumomab 2 abemaciclib 2 Vincristine 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡